Suchergebnisse - "Alahdab, Ahmad"

PubPharm (10)

1

Developing, validating, and comparing an analytical method to simultaneously detect z-drugs in urine samples using the QuEChERS approach with both liquid chromatography and gas chromatography-tandem mass spectrometry

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2024

von Chauhan, V. | Sharma, M. | Tiwari, A. | +8

2

Enhancement of Curcumin's Anti-Psoriatic Efficacy via Formulation into Tea Tree Oil-Based Emulgel

enthalten in: Gels (Basel, Switzerland) | 2023

von Reena, K. | Mittal, S. | Faizan, M. | +7

3

Synthesis of Quercetin-Loaded Silver Nanoparticles and Assessing Their Anti-Bacterial Potential

enthalten in: Micromachines | 2023

von Sharma, R. | Basist, P. | Alhalmi, A. | +3

4

Development and Characterization of Terbinafine-Loaded Nanoemulgel for Effective Management of Dermatophytosis

enthalten in: Gels (Basel, Switzerland) | 2023

von Phagna, M. | Badhwar, R. | Singh, M. | +4

5

Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment

enthalten in: Medicina (Kaunas, Lithuania) | 2023

von Farihi, A. | Bouhrim, M. | Chigr, F. | +7

6

Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLC

enthalten in: International journal of molecular sciences | 2023

von Gohlke, L. | Alahdab, A. | Oberhofer, A. | +5

7

Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate : In Vivo Evaluation and Bioavailability Enhancement

enthalten in: Pharmaceutics | 2023

von Saifi, Z. | Shafi, S. | Ralli, T. | +7

8

Nutritional Composition, Fatty Acids Profile, Mineral Content, Antioxidant Activity and Acute Toxicity of the Flesh of Helix aspesra Müller

enthalten in: Molecules (Basel, Switzerland) | 2023

von Aouji, M. | Imtara, H. | Rkhaila, A. | +6

9

3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer

enthalten in: Life (Basel, Switzerland) | 2023

von Er-Rajy, M. | El Fadili, M. | Imtara, H. | +7

10

Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line

enthalten in: Cells | 2021

von Saafan, H. | Alahdab, A. | Michelet, R. | +9

1
[1]